Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ion Beam Applications SA receives FDA approval of its new Compact Gantry


Wednesday, 16 Jul 2014 01:00am EDT 

Ion Beam Applications SA (IBA):Announces that it has received Marketing Authorization from the U.S. Food and Drug Administration (FDA) for its Compact Gantry Beam Line.Says the company anticipates that this regulatory approval will intensify the international interest in Proteus ONE, IBA's next generation proton therapy compact system. 

Company Quote

14.44
0.01 +0.07%
24 Oct 2014